1.
Multicenter Belgian experience of sofosbuvir (medical need program) in very difficult-to-treat HCV patients: safety and efficacy results.
2.
3.
4.
Multicenter Belgian experience of sofosbuvir medical need program in pre-and post-liver transplantation patients: safety and efficacy results.
Outcome of patients with hepatocellular carcinoma listed for liver transplantation before and after the Meld-based allocation system within Eurotransplant. A Belgian multicentre re...
The prognosis of hepatitis Delta infections in Belgium is poor and determined by the hepatitis Delta viremia.
Extended criteria for liver transplantation in hepatocellular carcinoma. A retrospective, multicentric validation study in Belgium.